Children's Hospital Association submitted comments on the cell and gene therapy request for information (RFI) from Sen. Bill Cassidy (R-La.), ranking member of the Senate Health, Education, Labor, and Pensions (HELP) Committee. Our response highlights the need to ensure children’s equitable access to these therapies and a strong national framework for payment and oversight.
CHA Response to Cell and Gene Therapy RFI
Cell and gene therapies have the potential to address unmet pediatric medical needs, reduce the need for costly chronic care, and help address health disparities.
Related Content
From Cornstarch to Gene Therapy: Life-Changing Treatment for GSD1a
The FDA approved a new gene therapy, providing hope and relief to children with GSD1a.
Nov. 05, 2026
3 Children’s Hospitals Building Stronger Support for Military-Connected Kids
We’re working with children’s hospitals to strengthen care, coverage, and support for military families.
Nov. 02, 2026
Building a Care Pathway for Military Families
How improving care coordination and establishing escalation processes improved families’ access to pediatric specialty care.
Oct. 28, 2026
From Cornstarch to Gene Therapy: Life-Changing Treatment for GSD1a
The FDA approved a new gene therapy, providing hope and relief to children with GSD1a.
Nov. 05, 2026
3 Children’s Hospitals Building Stronger Support for Military-Connected Kids
We’re working with children’s hospitals to strengthen care, coverage, and support for military families.
Nov. 02, 2026
Building a Care Pathway for Military Families
How improving care coordination and establishing escalation processes improved families’ access to pediatric specialty care.
Oct. 28, 2026